Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Assay Kit

MARV Nucleoprotein (NP) ELISA Kit

Catalog #:   KVV24401 Specific References (50) DATASHEET
Sample type: Plasma, Serum
Sensitivity: 0.15 ng/mL
Range: 0.07 - 50 ng/mL
Overview

Catalog No.

KVV24401

Specificity

Lake Victoria marburgvirus (MARV) Nucleoprotein (NP)

Detection method

Colorimetric

Sample type

Plasma, Serum

Assay type

Quantitative

Range

0.07 - 50 ng/mL

Sensitivity

0.15 ng/mL

Precision

CV<15%

Recovery

80-120%

Shipping

2-8 ℃

Stability and Storage

The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.

Data Image
References

From protein to immunology: comprehensive insights into Marburg virus vaccines, mechanism, and application., PMID:40025302

Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans., PMID:39771978

Cryo-EM structure of single-layered nucleoprotein-RNA complex from Marburg virus., PMID:39604358

Cheminformatics-based analysis identified (Z)-2-(2,5-dimethoxy benzylidene)-6-(2-(4-methoxyphenyl)-2-oxoethoxy) benzofuran-3(2H)-one as an inhibitor of Marburg replication by interacting with NP., PMID:39216611

Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine., PMID:38543955

Development of an Immunochromatography Assay to Detect Marburg Virus and Ravn Virus., PMID:38140590

Structural insights on the nucleoprotein C-terminal domain of Měnglà virus., PMID:37888996

Ebola virus VP35 perturbs type I interferon signaling to facilitate viral replication., PMID:37839549

Ebola Virus Activates IRE1α-Dependent XBP1u Splicing., PMID:36680162

First-in-human study to evaluate safety, tolerability, and immunogenicity of heterologous regimens using the multivalent filovirus vaccines Ad26.Filo and MVA-BN-Filo administered in different sequences and schedules: A randomized, controlled study., PMID:36197845

Combination treatment of mannose and GalNAc conjugated small interfering RNA protects against lethal Marburg virus infection., PMID:36114672

Structural insights into the interactions between lloviu virus VP30 and nucleoprotein., PMID:35649303

Structural insight into Marburg virus nucleoprotein-RNA complex formation., PMID:35246537

Marburg and Ebola Virus mRNA 3' Untranslated Regions Contain Negative Regulators of Translation That Are Modulated by ADAR1 Editing., PMID:34346762

Development of a multiplex microsphere immunoassay for the detection of antibodies against highly pathogenic viruses in human and animal serum samples., PMID:33095766

Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment., PMID:31337716

Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies., PMID:30875741

Phosphorylated VP30 of Marburg Virus Is a Repressor of Transcription., PMID:30135121

Pan-Filovirus Serum Neutralizing Antibodies in a Subset of Congolese Ebolavirus Infection Survivors., PMID:30107445

siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease., PMID:29106386

Unveiling a Drift Resistant Cryptotope within Marburgvirus Nucleoprotein Recognized by Llama Single-Domain Antibodies., PMID:29038656

Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging., PMID:29021793

Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus., PMID:28659479

Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus., PMID:28566377

ITCH E3 Ubiquitin Ligase Interacts with Ebola Virus VP40 To Regulate Budding., PMID:27489272

Novel Chemical Ligands to Ebola Virus and Marburg Virus Nucleoproteins Identified by Combining Affinity Mass Spectrometry and Metabolomics Approaches., PMID:27403722

Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses., PMID:27335383

Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges)., PMID:27070636

Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection., PMID:26962215

Delayed Time-to-Treatment of an Antisense Morpholino Oligomer Is Effective against Lethal Marburg Virus Infection in Cynomolgus Macaques., PMID:26901785

Molecular architecture of the nucleoprotein C-terminal domain from the Ebola and Marburg viruses., PMID:26894534

AVI-7288 for Marburg Virus in Nonhuman Primates and Humans., PMID:26200980

Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles., PMID:25793502

Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells., PMID:25370495

Interaction with Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells., PMID:25330247

Determination of specific antibody responses to the six species of ebola and Marburg viruses by multiplexed protein microarrays., PMID:25230936

Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA., PMID:25143366

Protection against lethal Marburg virus infection mediated by lipid encapsulated small interfering RNA., PMID:23990568

Mapping of conserved and species-specific antibody epitopes on the Ebola virus nucleoprotein., PMID:23702199

Generation and epitope mapping of a monoclonal antibody against nucleoprotein of Ebola virus., PMID:23457784

Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein., PMID:23035224

Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism., PMID:23028316

Rapid detection of filoviruses by real-time TaqMan polymerase chain reaction assays., PMID:23001480

Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread., PMID:21987762

Characterization of filovirus protein-protein interactions in mammalian cells using bimolecular complementation., PMID:21987757

Advances in virus-like particle vaccines for filoviruses., PMID:21987741

Detection of all known filovirus species by reverse transcription-polymerase chain reaction using a primer set specific for the viral nucleoprotein gene., PMID:21093485

Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles., PMID:20504928

Development and evaluation of a simple assay for Marburg virus detection using a reverse transcription-loop-mediated isothermal amplification method., PMID:20421440

Discovery of common marburgvirus protective epitopes in a BALB/c mouse model., PMID:19712478

Datasheet
$ 1128
Product specifications
96 T 1128

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

MARV Nucleoprotein (NP) ELISA Kit [KVV24401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only